| Product NDC: | 0009-3116 |
| Proprietary Name: | Cleocin T |
| Non Proprietary Name: | clindamycin phosphate |
| Active Ingredient(s): | 10 mg/mL & nbsp; clindamycin phosphate |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0009-3116 |
| Labeler Name: | Pharmacia and Upjohn Company |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA050537 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19800620 |
| Package NDC: | 0009-3116-14 |
| Package Description: | 60 mL in 1 CARTON (0009-3116-14) |
| NDC Code | 0009-3116-14 |
| Proprietary Name | Cleocin T |
| Package Description | 60 mL in 1 CARTON (0009-3116-14) |
| Product NDC | 0009-3116 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | clindamycin phosphate |
| Dosage Form Name | SOLUTION |
| Route Name | TOPICAL |
| Start Marketing Date | 19800620 |
| Marketing Category Name | NDA |
| Labeler Name | Pharmacia and Upjohn Company |
| Substance Name | CLINDAMYCIN PHOSPHATE |
| Strength Number | 10 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient] |